2024

• Sweeney, A., Rush, A., Stevens, J., Sutherland, G. (2024). A Survey of Community Perceptions on Brain Donation for Research. Biopreservation and Biobanking. [More Information]
• Friske, M., Hitzemann, R., Philips, M., Fei, S., Sommer, W., Mayfield, R., Spanagel, R., Torrico, E., Haas, M., Borruto, A., Sutherland, G., et al (2024). A systematic review and meta-analysis on the transcriptomic signatures in alcohol use disorder. Molecular Psychiatry. [More Information]
• Zillich, L., Cetin, M., Hummel, E., Poisel, E., Fries, G., Frank, J., Streit, F., Foo, J., Sirignano, L., Friske, M., Sutherland, G., et al (2024). Biological aging markers in blood and brain tissue indicate age acceleration in alcohol use disorder. Alcohol: Clinical and Experimental Research, 48(2), 250-259. [More Information]
• Balez, R., Stevens, C., Lenk, K., Maksour, S., Sidhu, K., Sutherland, G., Ooi, L. (2024). Increased Neuronal Nitric Oxide Synthase in Alzheimer's Disease Mediates Spontaneous Calcium Signaling and Divergent Glutamatergic Calcium Responses. Antioxidants & Redox Signaling. [More Information]
• Rush, A., Weil, C., Siminoff, L., Griffin, C., Paul, C., Mahadevan, A., Sutherland, G. (2024). The Experts Speak: Challenges in Banking Brain Tissue for Research. Biopreservation and Biobanking, 22(2), 179-184. [More Information]

2023

• Adams, C., Perry, N., Conigrave, J., Hurzeler, T., Stevens, J., Yacou Dunbar, K., Sweeney, A., Lee, K., Sutherland, G., Haber, P., Morley, K. (2023). Central markers of neuroinflammation in alcohol use disorder: A meta-analysis of neuroimaging, cerebral spinal fluid, and postmortem studies. Alcoholism: Clinical and Experimental Research, 47(2), 197-208. [More Information]
• Allwright, M., Mundell, H., Sutherland, G., Austin, P., Guennewig, B. (2023). Machine learning analysis of the UK Biobank reveals IGF-1 and inflammatory biomarkers predict Parkinson's disease risk. PloS One, 18(5), e0285416. [More Information]
• Allwright, M., Mundell, H., McCorkindale, A., Lindley, R., Austin, P., Guennewig, B., Sutherland, G. (2023). Ranking the risk factors for Alzheimer's disease; findings from the UK Biobank study. Aging Brain, 3, 100081. [More Information]
• Brase, L., You, S., D'Oliveira Albanus, R., Del-Aguila, J., Dai, Y., Novotny, B., Soriano-Tarraga, C., Dykstra, T., Fernandez, M., Budde, J., Sutherland, G., et al (2023). Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers. Nature Communications, 14(1), 2314. [More Information]
• Patrick, E., Canete, N., Iyengar, S., Harman, A., Sutherland, G., Yang, P. (2023). Spatial analysis for highly multiplexed imaging data to identify tissue microenvironments. Cytometry Part A, 103, 593-599. [More Information]
• Lee, J., Harney, D., Teo, J., Kwok, J., Sutherland, G., Larance, M., Don, A. (2023). The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus. Molecular Neurodegeneration, 18(1). [More Information]

2022

• Smith, C., Sheedy, D., McEwen, H., Don, A., Kril, J., Sutherland, G. (2022). Lipidome changes in alcohol-related brain damage. Journal of Neurochemistry, 160(2), 271-282. [More Information]
• Hooshmand, K., Halliday, G., Pineda Gonzalez, S., Sutherland, G., Guennewig, B. (2022). Overlap between Central and Peripheral Transcriptomes in Parkinson's Disease but Not Alzheimer's Disease. International Journal of Molecular Sciences, 23(9), 5200. [More Information]
• Paasila, P., Aramideh, J., Sutherland, G., Graeber, M. (2022). Synapses, Microglia, and Lipids in Alzheimer’s Disease. Frontiers in Neuroscience, 15, 778822. [More Information]
• McCorkindale, A., Patrick, E., Duce, J., Guennewig, B., Sutherland, G. (2022). The Key Factors Predicting Dementia in Individuals With Alzheimer’s Disease-Type Pathology. Frontiers in Aging Neuroscience, 14(Open Access), Article number 831967 - 1-Article number 831967 - 8. [More Information]
• McCorkindale, A., Mundell, H., Guennewig, B., Sutherland, G. (2022). Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers. International Journal of Molecular Sciences, 23(13). [More Information]

2021

• Guennewig, B., Lim, J., Marshall, L., McCorkindale, A., Paasila, P., Patrick, E., Kril, J., Halliday, G., Cooper, A., Sutherland, G. (2021). Defining early changes in Alzheimer's disease from RNA sequencing of brain regions differentially affected by pathology. Scientific Reports, 11(1), 4865. [More Information]
• Paasila, P., Fok, S., Flores-Rodriguez, N., Sajjan, S., Svahn, A., Dennis, C., Holsinger, D., Kril, J., Becker, T., Banati, R., Sutherland, G., Graeber, M. (2021). Ground state depletion microscopy as a tool for studying microglia-synapse interactions. Journal of Neuroscience Research, 99(6), 1515-1532. [More Information]
• O'Rourke, M., Viengkhou, B., Smith, C., Sonderegger, L., Padula, M., Sutherland, G., Hofer, M., Crossett, B. (2021). Matrix phase fractionation: Investigating the compromise between dynamic range of analyte extraction and spatial resolution in mass spectrometry imaging. Rapid Communications in Mass Spectrometry, 35(13), e9106. [More Information]
• Parvaneh, M., Witting, P., Ku, J., Moradi, T., Inan Eroglu, E., Freedman, B., Sutherland, G., McCorkindale, A., Guennewig, B., Choowong, P., Bell-Anderson, K., Cooney, G., Eberhard, J., et al (2021). Periodontitis induces endothelial dysfunction in mice. Scientific Reports, 11(1), 14993. [More Information]
• Tsatsanis, A., McCorkindale, A., Wong, B., Patrick, E., Ryan, T., Evans, R., Bush, A., Sutherland, G., Sivaprasadarao, A., Guennewig, B., et al (2021). The acute phase protein lactoferrin is a key feature of Alzheimer's disease and predictor of Aβ burden through induction of APP amyloidogenic processing. Molecular Psychiatry, 26(10), 5516-5531. [More Information]
• Rush, A., Sutherland, G. (2021). The future of brain banking in Australia: an integrated brain and body biolibrary. Medical Journal of Australia, 214(10), 447-449.e1. [More Information]

2020

• Newman, M., Nik, H., Sutherland, G., Hin, N., Kim, W., Halliday, G., Jayadev, S., Smith, C., Laird, A., Lucas, C., et al (2020). Accelerated loss of hypoxia response in zebrafish with familial Alzheimer's disease-like mutation of presenilin 1. Human Molecular Genetics, 29(14), 2379-2394. [More Information]
• Paasila, P., Davies, D., Sutherland, G., Goldsbury, C. (2020). Clustering of activated microglia occurs before the formation of dystrophic neurites in the evolution of A Beta plaques in Alzheimer's disease. Free Neuropathology, 1, 1-18. [More Information]
• Shen, K., Welton, T., Lyon, M., McCorkindale, A., Sutherland, G., Burnham, S., Fripp, J., Martins, R., Grieve, S. (2020). Structural core of the executive control network: A high angular resolution diffusion MRI study. Human Brain Mapping, 41(5), 1226-1236. [More Information]

2019

• O'Rourke, M., Smith, C., Tse, B., Sutherland, G., Crossett, B., Padula, M. (2019). 'What did I do wrong?' An empirical evaluation of sample preparation methodologies in matrix-assisted laser desorption/ionization-mass spectrometry imaging. Future Science OA, 5(4), 1-16. [More Information]
• Ke, Y., Chan, G., Stefanoska, K., Au, C., Bi, M., Muller, J., Przybyla, M., Feiten, A., Prikas, E., Halliday, G., Piguet, O., Kiernan, M., Kassiou, M., Hodges, J., Loy, C., Kril, J., Sutherland, G., et al (2019). CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation. Journal of Biological Chemistry, 294(38), 14149-14162. [More Information]
• O'Rourke, M., Smith, C., de la Monte, S., Sutherland, G., Padula, M. (2019). Higher Mass Accuracy MALDI-TOF/TOF Lipid Imaging of Human Brain Tissue in Alzheimer's Disease. Current Protocols in Molecular Biology, 126(1), e86. [More Information]
• McCorkindale, A., Sizemova, A., Sheedy, D., Kril, J., Sutherland, G. (2019). Re-investigating the effects of chronic smoking on the pathology of alcohol-related human brain damage. Alcohol, 76, 11-14. [More Information]
• Paasila, P., Davies, D., Kril, J., Goldsbury, C., Sutherland, G. (2019). The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology. Brain Pathology, 29(6), 726-740. [More Information]

2018

• Lumsden, A., Rogers, J., Majd, S., Newman, M., Sutherland, G., Verdile, G., Lardelli, M. (2018). Dysregulation of neuronal iron homeostasis as an alternative unifying effect of mutations causing familial alzheimer's disease. Frontiers in Neuroscience, 12(AUG), 1-21. [More Information]
• Youssef, P., Chami, B., Lim, J., Middleton, T., Sutherland, G., Witting, P. (2018). Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer's disease. Scientific Reports, 8(1), 11553. [More Information]
• Littlejohn, M., Turner, S., Walker, C., Berry, S., Tiplady, K., Sherlock, R., Sutherland, G., Swift, S., Garrick, D., Lacy-Hulbert, S., et al (2018). Identification of an immune modulation locus utilising a bovine mammary gland infection challenge model. Journal of Dairy Research, 85(2), 185-192. [More Information]
• de la Monte, S., Kay, J., Yalcin, E., Kril, J., Sheedy, D., Sutherland, G. (2018). Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics. Alcohol, 67, 51-63. [More Information]
• Morley, K., Baillie, A., van den Brink, W., Chitty, K., Brady, K., Back, S., Seth, D., Sutherland, G., Leggio, L., Haber, P. (2018). N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research. Expert Opinion on Investigational Drugs, 27(8), 667-675. [More Information]
• O'Rourke, M., Padula, M., Smith, C., Youssef, P., Cordwell, S., Witting, P., Sutherland, G., Crossett, B. (2018). Optimal Preparation of Formalin Fixed Samples for Peptide Based Matrix Assisted Laser Desorption/Ionization Mass Spectrometry Imaging Workflows. Journal of Visualized Experiments, 131(131), e56778. [More Information]

2017

• Sutherland, G., Lim, J., Srikanth, V., Bruce, D. (2017). Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia. Journal of Alzheimer's Disease, 59(2), 393-403. [More Information]
• Dennis, C., Suh, L., Rodriguez, M., Kril, J., Sutherland, G. (2017). Response to: Comment on Human adult neurogenesis across the ages: An immunohistochemical study"". Neuropathology and Applied Neurobiology, 43(5), 452-454. [More Information]
• Papp-Peka, A., Tong, M., Kril, J., de la Monte, S., Sutherland, G. (2017). The differential effects of alcohol and nicotine-specific Nitrosamine Ketone on White Matter Ultrastructure. Alcohol and Alcoholism, 52(2), 165-171. [More Information]

2016

• Jayne, T., Newman, M., Verdile, G., Sutherland, G., Munch, G., Musgrave, I., Moussavi Nik, S., Lardelli, M. (2016). Evidence for and Against a Pathogenic Role of Reduced (yamma)-Secretase Activity in Familial Alzheimer's Disease. Journal of Alzheimer's Disease, 52(3), 781-799. [More Information]
• Dennis, C., Suh, L., Rodriguez, M., Kril, J., Sutherland, G. (2016). Human adult neurogenesis across the ages: An immunohistochemical study. Neuropathology and Applied Neurobiology, 42(7), 621-638. [More Information]
• Ittner, A., Chua, S., Bertz, J., Volkerling, A., van der Hoven, J., Gladbach, A., Przybyla, M., Bi, M., van Hummel, A., Stevens, C., Suh, L., Sutherland, G., Kril, J., Silva, A., Mackay, J., et al (2016). Site-specific phosphorylation of tau inhibits amyloid-b toxicity in Alzheimer's mice. Science, 354(6314), 904-908. [More Information]
• McCorkindale, A., Sheedy, D., Kril, J., Sutherland, G. (2016). The effects of chronic smoking on the pathology of alcohol-related brain damage. Alcohol, 53, 35-44. [More Information]
• Sutherland, G., Sheedy, D., Stevens, J., McCrossin, T., Smith, C., Van Roijen, M., Kril, J. (2016). The NSW brain tissue resource centre: Banking for alcohol and major neuropsychiatric disorders research. Alcohol, 52, 33-39. [More Information]
• Chami, B., Steel, A., de la Monte, S., Sutherland, G. (2016). The rise and fall of insulin signaling in Alzheimer's disease. Metabolic Brain Disease, 31(3), 497-515. [More Information]

2015

• van Eersel, J., Stevens, C., Przybyla, M., Gladbach, A., Stefanoska, K., Chan, C., Ong, W., Hodges, J., Sutherland, G., Kril, J., Ittner, L., et al (2015). Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration. Neuropathology and Applied Neurobiology, 41(7), 906-925. [More Information]

2014

• Sutherland, G., Sheedy, D., Sheahan, P., Kaplan, W., Kril, J. (2014). Comorbidities, Confounders, and the White Matter Transcriptome in Chronic Alcoholism. Alcoholism: Clinical and Experimental Research, 38(4), 994-1001. [More Information]
• Newman, J., Todorovic, M., Silburn, P., Sutherland, G., Mellick, G. (2014). Lack of reproducibility in re-evaluating associations between GCH1 polymorphisms and Parkinson’s disease and isolated dystonia in an Australian case-control group. Parkinsonism and Related Disorders, 20(6), 668-670. [More Information]
• Dennis, C., Sheahan, P., Graeber, M., Sheedy, D., Kril, J., Sutherland, G. (2014). Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy. Metabolic Brain Disease, 29(4), 1027-1039. [More Information]
• Sutherland, G., Sheedy, D., Kril, J. (2014). Neuropathology of Alcoholism. In Edith V. Sullivan and Adolf Pfefferbaum (Eds.), Handbook of Clinical Neurology, Vol 125, (pp. 603-615). Elsevier Inc. [More Information]
• Mills, J., Sheahan, P., Lai, D., Kril, J., Janitz, M., Sutherland, G. (2014). The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer's disease patients. Molecular Biology Reports, 41(10), 6365-6376. [More Information]
• Sutherland, G., Sheedy, D., Kril, J. (2014). Using Autopsy Brain Tissue to Study Alcohol-Related Brain Damage in the Genomic Age. Alcoholism: Clinical and Experimental Research, 38(1), 1-8. [More Information]

2013

• Ooi, L., Sidhu, K., Poljak, A., Sutherland, G., O’Connor, M., Sachdev, P., Munch, G. (2013). Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease. Journal of Neural Transmission, 120(1), 103-111. [More Information]
• Sutherland, G., Chami, B., Youssef, P., Witting, P. (2013). Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product? Redox Report, 18(4), 134-141. [More Information]
• Sutherland, G., Sheahan, P., Matthews, J., Dennis, C., Sheedy, D., McCrossin, T., Curtis, M., Kril, J. (2013). The effects of chronic alcoholism on cell proliferation in the human brain. Experimental Neurology, 247, 9-18. [More Information]

2012

• Sutherland, G., Kril, J. (2012). Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age. In Carlos M. Contreras (Eds.), Neuroscience - Dealing With Frontiers, (pp. 389-428). Rijeka, Croatia: InTech Publishers. [More Information]
• Newman, J., Sutherland, G., Boyle, R., Limberg, N., Blum, S., O'Sullivan, J., Silburn, P., Mellick, G. (2012). Common polymorphisms in dystonia-linked genes and susceptibility to the sporadic primary dystonias. Parkinsonism and Related Disorders, 18(4), 351-357. [More Information]
• Sutherland, G., Sidhu, K. (2012). Pluripotent Stem Cells for (Neurodegenerative) Disease Modelling. In Kuldip Sidhu (Eds.), Frontiers in Pluripotent Stem Cells Research and Therapeutic Potentials: Bench-to-Bedside, (pp. 205-219). United Arab Emirates: Bentham Science Publishers. [More Information]
• Sutherland, G. (2012). Transcriptomic studies of Alzheimer's disease. The Australian Neuroscience Society 32nd Annual Meeting, Kent Town, South Australia: Australian Neuroscience Society.

2011

• Sutherland, G. (2011). A transciptomic analusis of Parkinson's disease. Dimentia, Ageing and Neurodegenerative Diseases group, Auckland: Dementia, Ageing and neurodegenerative Diseases group (ANS).
• Sutherland, G. (2011). A transcrptomics approach to preclinical Alzheimer's disease. The Australian Neuroscience Society 31st Annual Meeting, Kent Town, South Australia: Australian Neuroscience Society.
• Sutherland, G., Siebert, G., Kril, J., Mellick, G. (2011). Knowing Me, Knowing You: Can a Knowledge of Risk Factors for Alzheimer's Disease Prove Useful in Understanding the Pathogenesis of Parkinson's Disease? Journal of Alzheimer's Disease, 25(3), 395-415. [More Information]
• Cook, A., Vitale, A., Ravishankar, S., Matigian, N., Sutherland, G., Shan, J., Sutharsan, R., Perry, C., Silburn, P., Mellick, G., et al (2011). NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease. PloS One, 6(7), 1-14. [More Information]
• Sutherland, G., Janitz, M., Kril, J. (2011). Understanding the pathogenesis of Alzheimer's disease: will RNA-Seq realize the promise of transcriptomics? Journal of Neurochemistry, 116(6), 937-946. [More Information]

2010

• Sutherland, G. (2010). Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities. Expert Review of Molecular Diagnostics, 10(8), 1035-1050. [More Information]

2009

• Sutherland, G., Matigian, N., Chalk, A., Anderson, M., Silburn, P., Mackay-Sim, A., Wells, C., Mellick, G. (2009). A cross-study transcriptional analysis of Parkinson's disease. PloS One, 4(3), 1-8. [More Information]
• Sutherland, G., Rowe, D. (2009). Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? Movement Disorders, 24(6), 833-838. [More Information]
• Sutherland, G., Siebert, G., Newman, J., Silburn, P., Boyle, R., O'Sullivan, J., Mellick, G. (2009). Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease. Movement Disorders. [More Information]
• Sutherland, G. (2009). Transcriptional Analysis of Parkinson's disease. The Australian and New Zealand Society for Neuropathology Joint Scientific Meeting, Sydney: Australian and New Zealand Society for Neuropathology.

2008

• Sutherland, G. (2008). Do polymorphisms in the familial parkinsonism genes contribute to risk for sporadic Parkinson's disease? 4th Australian Health and Medical Research Congress (AHMRC), Brisbane: The Australian Society for Medical Research.
• Sutherland, G., Mellick, G., Newman, J., Double, K., Stevens, J., Lee, L., Rowe, D., Silburn, P., Halliday, G. (2008). Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson's disease. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 147B (4), 495-499. [More Information]
• Sutherland, G. (2008). Using human olfactory-derived cell cultures to study Parkinson's disease (PD). 4th Australian Health and Medical Research Congress (AHMRC), Brisbane: The Australian Society for Medical Research.

2007

• Sutherland, G., Nowak, G., Halliday, G., Kril, J. (2007). Tau isoform expression in frontotemporal dementia without tau deposition. Journal of Clinical Neuroscience, 14(12), 1182-1185. [More Information]

2005

• Ford, C., Stanfield, A., Spelman, R., Smits, B., Ankersmidt-Udy, A., Cottier, K., Holloway, H., Walden, A., Al-Wahb, M., Bohm, E., et al (2005). A mutation in bovine keratin 5 causing epidermolysis bullosa simplex, transmitted by a mosaic sire. Journal of Investigative Dermatology, 124(6), 1170-1176. [More Information]

2004

• Ankersmidt-Udy, A., Stanfield, A., Ford, C., Sutherland, G., Spelman, R., Snell, R. (2004). A Bovine Genotyping Test. Patent No. 525023. New Zealand.